This report describes the clinical and hematological characteristics of two young siblings with chronic hypochromic microcytic anemia and high serum iron concentrations. Further tests have revealed that neither patient suffers from thalassemia, hemoglobinopathy, or pyridoxine-responsive anemia. Subsequent examinations have disclosed an error in iron metabolism in these patients characterized by massive hepatic iron deposition and absent stainable bone marrow iron stores. The association of this discrepancy with the chronic hypochromic anemia present in these two siblings is unique and has stimulated a series of special studies concerning their iron metabolism.
Case Reports 1) A. A., a 12a-year-old boy of French extraction, was born at term weighing 6 pounds 4 ounces. He was first seen in the Children's Hospital Medical Center at the age of 81 years for treatment of refractory anemia; the patient had been pale most of his life. Various hematinics, such as iron, vitamin B12, and folic acid, had been tried orally and parenterally, alone or in combination, without success.
Physical examination revealed an undersized, pale boy with dry, hyperkeratotic skin. The liver and spleen were palpable 3 and 4 cm, respectively, below the costal margins.
The pertinent hematological findings are presented in Tables I and II . Stained films of the peripheral blood showed markedly hypochromic microcytic erythrocytes. There was little variation in size and shape of the red * Submitted for publication May 14, 1963 ; accepted November 21, 1963. Supported by grants from the John A. Hartford
Foundation and from the Medical Foundation, Inc. Requests for reprints should be addressed to Louis K. Diamond, M.D., Children's Hospital Medical Center, Boston, Mass. cells, and no target cells were present. Nucleated red blood cells were not seen. The serum iron concentration (1) was elevated. The osmotic fragility test of incubated erythrocytes revealed that hemolysis began in 0.4%o saline solution and was complete in 0.1% saline solution. An iliac bone marrow aspiration revealed a hypercellular specimen with erythroid hyperplasia (erythroid: myeloid ratio of 2.5: 1). Most of the erythroid elements were normoblasts with scanty and irregular basophilic cytoplasm. No megaloblastic changes were seen. Special iron stains (2) failed to show any siderocytes or sideroblasts; in addition, the reticulum cells were devoid of iron.
Liver function tests revealed a cephalin flocculation of 3+, thymol flocculation of 4+, and thymol turbidity of 3 +. Alkali resistant hemoglobin (3) and A2 hemoglobin concentrations (4) were normal. Free erythrocyte protoporphyrin was increased (5) .
Since 
Methods and Results
Because of the similarity of the syndrome in these two siblings, both patients were thought to suffer from the same disease. Consequently, some of the studies of the boy were not repeated in the younger sibling.
Biopsies
Liver biopsy was obtained from both patients. Microscopic examination of the sections from patient A. A. revealed mild fibrosis in portal areas extending diffusely into the lobules in some regions. These fibrotic changes were not present in patient M. A. A fine, greenish-yellow pigment, strongly Prussian-blue-positive, was present in many of the liver cells in both patients ( Figure  1 liver and marrow biopsies were stained for iron and reviewed as unknowns.2
Ferrokinetics and erythrocyte survival
Methods. Studies of plasma and red cell iron turnover, together with in vivo measurement of iron localization, were performed with Fe59 citrate by previously described methods (8) (9) (10) . In addition, hemin was isolated from peripheral blood (11) , and its Fe59 specific activity was assessed. Patient A. A. first received 4 ,uc Fe59 citrate incubated with 10 ml of compatible homologous plasma. The amount of carrier iron was calculated to be within the iron binding capacity of the plasma for this and subsequent studies. During the second study of A. A., he received 5 uc Fe59 citrate bound to autologous plasma.
Twenty uc of Na2Cr51O4 was bound to autolo-gous red cells for measurement of red cell survival during the first Fe59 study (10) .
Patient M. A. received a single dose of 2 Muc Fe59 citrate bound to autologous plasma. Plasma iron clearance, red cell iron turnover, rate of appearance of Fe59 in circulating hemin, and in vivo localization of Fe59 were estimated by the techniques described above.
Results. In patient A. A., the results of studies performed in vivo both with homologous and with autologous Fe59-labeled plasma were not substantially different (Figures 2 and 3 ). The salient findings were these: normal plasma Fe59 clearance despite elevation of the serum iron, rapid accumulation of a substantial fraction of the Fe59 in the liver, 45 to 65%o of the Fe59 in the red cells 10 days after its administration, and appearance of Fe59 in circulating red cells and in hemin at identical and normal rates. The latter is more clearly demonstrated in Figure 6 . The red cell life span as estimated with Cr51 was normal. The total red cell volume was 510 ml or 16.1 513 N. T. SHAHIDI, D. G. NATHAN, AND L. K. DIAMOND ml per kg body weight. At a red cell renewal rate of 1%o per day, the daily red cell production was 0.16 ml per kg per day. The mean corpuscular hemoglobin concentration was 27 g per 100 ml red cells. Therefore, the daily hemoglobin production was only 43 mg per kg per day, a value approximately half of that predicted for a normal individual. Calculation of daily hemoglobin production from Fe59 turnover data produced a value of 135 mg per kg per day, approximately three times the actual figure. This error was undoubtedly induced by marked overestimation of the rate of Fe59 accumulation in the marrow (12) . The contribution of the plasma: liver equilibrium to the turnover of Fe59 in the plasma was underestimated.
The findings concerning patient M. A. were very similar to those of her brother (Figures 4  and 6 ). There was a higher accumulation of Fe59 in the red cells, hence a less striking accumulation in the liver. The Cr51 red cell life span was not estimated. Infusion of colloidal iron. Two hundred fifty mg of iron saccharide was added to 250 cc of 5%o dextrose, and the solution was infused into patient A. A. over a 4-hour period without any incident. This procedure was repeated the next day. A bone marrow aspiration was performed after the second infusion. No siderocytes or sideroblasts could be demonstrated. A few hemosiderin granules within macrophages were seen, but very rarely. Normally macrophages containing iron granules can be readily demonstrated in large numbers in the bone marrow aspirate after colloidal iron infusion (15) . The iron saccharide infusion did not result in any significant rise in the hemoglobin concentration or reticulocyte count.
Infusion of colloidal gold. The injection of colloidal gold (Au198) into the circulation of humans or animals is followed by a rapid fall in radioactivity that attains half of its initial value within the first 5 minutes (16 
Therapeutic trials
The therapeutic trials were performed only in the boy who, in addition to the usual hematinics, received sufficient pyridoxine (17) (18) (19) (20) and oral liver extract (21) to exclude any potential benefit from these substances. Moreover, a tryptophan loading test performed before the administration of pyridoxine failed to reveal any abnormal tryptophan metabolites, such as 3-hydroxykynurenine or anthranilic acid.
To examine the possibility that a large dose of transferrin would augment the incorporation of iron into erythroid cells by increasing the transferrin-erythroid cell iron exchange (14) , he was infused with 10 g of purified iron-saturated transferrin. The serum iron and unsaturated iron binding capacity (UIBC) were measured before and after infusion and were followed over several days. Before stores, and absent sideroblasts were compatible with this diagnosis. Indeed, the anemia observed in these children is due to iron deficiency of the bone marrow, but the associated elevation of serum iron concentration and massive hepatic iron deposition are unique features that considerably complicate the problem. These two children differ markedly from patients with refractory hypochromic hypersideremic anemia whose case histories have been reported to date (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . Three major functions (iron stores, erythrocyte life span, and kinetics of Fe59 utilization) distinguish hypersideremic anemia from the present cases.
1) In the cases of hypersideremic anemia described to date, the marrow and hepatic reticulum cells are loaded with iron, sideroblasts are abundant, and hepatic cells often have increased iron granules. By contrast, iron is conspicuously absent from the marrow of the children reported here, and iron infusion did not significantly increase the bone marrow iron stores of patient A. A. The hepatic cells, however, are laden with iron. This disparity between the hepatic and marrow iron storage sites is unique in our experience and contrasts with the studies of Gale, Torrance, and Bothwell (39) , which emphasize the linear relationship between hepatic and marrow stainable iron stores in normal individuals and in individuals with iron loading syndromes.
2) The red cell life span of patients with hypochromic hypersideremic anemia is usually moderately shortened, but in patient A. A. the life span was normal, as estimated with Cr51.
3) In hypochromic hypersideremic anemia, plasma Fe59 clearance is often rapid, with accumulation of Fe59 in the marrow and liver, but the subsequent appearance of Fe59 in peripheral red cells is slow and markedly decreased. Thus, in previously studied cases (25, (27) (28) (29) (30) 34) , the calculated percentage of uptake of Fe59 by red cells, 10 days after iv administration of radioiron, varied from 5 to 36%o. Of this reduced Fe59 incorporation, an even smaller fraction may actually be located in the hemoglobin. Much of the labeled iron may be detected in the stroma (35) . These findings are consistent with the high ratio of nonhemoglobin iron to hemoglobin iron in the red cells of patients with hypochromic hypersideremic anemia (29, 30) . Various defects in heme synthesis have been evoked to account for these observations, none of which have been detected in the children reported here. On the contrary, the plasma iron clearance was not remarkably rapid, and although an abnormally high fraction of the administered Fe59 appeared in the liver, from 45 to 80%o was incorporated into newly formed red cells. In addition, F59 appeared in the red cells and the hemoglobin at equal rates.
To be sure, the Fe59 data are not normal in these children. In ordinary iron deficiency anemia the rate of removal of Fe59 from hyposideremic plasma is very rapid, and all of the Fe59 is swiftly incorporated into newly formed red cells. In these children, only the bone marrow is iron deficient. The administered Fe59 mixes in a large plasma iron pool; a significant moiety is rapidly deposited in the liver; the remainder is utilized for hemoglobin synthesis by the marrow. But the amount of iron utilized by the marrow is obviously inadequate for the demands of hemoglobin synthesis in these children. The marrow, which requires a larger fraction of the total body iron pool, fails to partake sufficiently of the extramedullary sideroplethora, and iron deficiency anemia ensues. The nature of this famine in the face of plenty is subject to conjecture, since none of the studies reported here have revealed its mechanism. That the abnormality is probably congential is suggested by the appearance of the disorder in two young siblings. In addition, the nature of the congenital lesion appears to be one of insufficient iron delivery to the erythroid marrow rather than underutilization of iron and ineffective erythropoiesis. Two linked observations emphasize the lesion of iron delivery. These are the absence of stainable iron in the marrow in a hypochromic anemia and the failure to achieve 100% uptake of a tracer dose of iron by the red cells despite deficient marrow iron stores.
Several possibilties regarding the nature of the insufficient iron delivery to the marrow in these children have been considered, but none is definitive. There is much controversy (42) regarding the possible role of the reticulum cell as an intermediary between transferrin iron and hemoglobin iron. Studies of canine iron metabolism with Fess do not suggest an important contribution to hemoglobin synthesis by the marrow reticulum cell (43) . Indeed, one clinical experience belies such a function. A patient with hereditary hemorrhagic telangiectasia has been observed at the Peter Bent Brigham Hospital for many years. He has received massive amounts of parenteral saccharated iron oxide and iron dextran. His red cells are severely hypochromic; his serum iron value 1 week after a 500-mg intravenous dose of iron dextran is usually 10 to 20 Ag per 100 ml. Yet the reticulum cells of the bone marrow are so full of iron that the marrow smear appears grossly blue after Prussian blue staining. Certainly these cells are unable to provide sufficient iron for hemoglobinization. Only when the plasma iron is normalized does this patient increase his hemoglobin production.
Thus, various inquiries into the nature of the defect in iron metabolism that exists in the children reported here have not led to definition either of their pathophysiology or their treatment. They have, however, provided evidence that normal saturated transferrin alone is not sufficient to furnish the marrow with a flow of iron adequate for the demands of hemoglobin synthesis.
Summary
A new type of hypochromic microcytic anemia associated with an error of iron metabolism has been described in two siblings. Both children have had anemia since infancy, and all therapeutic efforts have been unsuccessful. Special investigations, including studies of transferrin and ferrokinetics, showed no defect in transferrin or the qualitative aspects of heme synthesis. Iron stains revealed a marked discrepancy between the iron storage sites. Although the liver parenchymal cells were surcharged with ferruginous material, the Kupffer cells and the macrophages and erythroid cells in the bone marrow contained none. The existence of iron-deficient erythrocytes in these patients despite adequate transferrin-iron complex suggests that this complex does not alone assure' iron delivery to the erythroid bone narrow sufficient for the demands of hemoglobin sy thesis.
